Semaglutide for psoriasis and obesity
Treatments studied
Part of Hormones & metabolism, Skin clinical trials.
This trial tests if semaglutide, a medicine used for diabetes and weight loss, can help people with both psoriasis and obesity. You may qualify if you have moderate to severe psoriasis, a high body weight, and are of Chinese descent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had psoriasis for at least 6 months
- You are between 18 and 75 years old
- Your body mass index (BMI) is 30 or higher, or 27 or higher with a weight-related condition like high blood pressure or type 2 diabetes
- Your psoriasis is moderate to severe (doctor will assess)
- You are of Chinese ethnicity
- You are on a stable treatment for psoriasis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if semaglutide, a diabetes and weight-loss medication, can improve psoriasis symptoms and reduce inflammation. It may be an option for people with both psoriasis and overweight or obesity, with or without diabetes.
This study tests whether a medicine called a GLP-1 receptor agonist (a type of drug often used for weight and diabetes) can help people with psoriatic arthritis who are overweight but not diabetic. It may reduce joint symptoms and help with weight loss.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.
This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.
This trial studies whether semaglutide (a diabetes-type weight-loss injection) helps adults with HIV lose weight. It also checks that it’s safe for people whose HIV is well controlled on regular treatment.
Hear when a new Psoriasis (PsO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.